• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类卵巢肿瘤中自然杀伤活性存在缺陷:原位存在的形态学明确的效应细胞数量较少。

Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.

作者信息

Introna M, Allavena P, Biondi A, Colombo N, Villa A, Mantovani A

出版信息

J Natl Cancer Inst. 1983 Jan;70(1):21-6.

PMID:6337291
Abstract

Tumor-associated lymphocytes (TAL) were isolated from 17 ascites and 7 solid ovarian carcinomas. TAL had defective natural killer (NK) activity against K562. Large granular lymphocytes, the morphologically identified effectors of NK activity, were poorly represented in TAL from ovarian carcinomas as compared to peripheral blood lymphocytes from the same patients or from normal donors. Similar results were obtained when effectors of NK activity were identified with an anti-NK (HNK-1) monoclonal antibody. When four TAL preparations were separated on discontinuous Percoll gradients, they were able to be enriched for NK activity and large granular lymphocyte morphology in the lower density fractions as observed with blood. These observations suggested that a low concentration of the relevant effector cells was the major factor determining the defective NK cytotoxicity of lymphoid cells associated with these human neoplasms.

摘要

从17例腹水型和7例实体型卵巢癌中分离出肿瘤相关淋巴细胞(TAL)。TAL对K562的自然杀伤(NK)活性存在缺陷。形态学上确定的NK活性效应细胞——大颗粒淋巴细胞,与同一患者或正常供体的外周血淋巴细胞相比,在卵巢癌的TAL中所占比例较低。当用抗NK(HNK-1)单克隆抗体鉴定NK活性效应细胞时,也得到了类似结果。当四种TAL制剂在不连续的Percoll梯度上分离时,与血液情况一样,它们能够在较低密度级分中富集NK活性和大颗粒淋巴细胞形态。这些观察结果表明,相关效应细胞浓度低是决定与这些人类肿瘤相关的淋巴细胞NK细胞毒性缺陷的主要因素。

相似文献

1
Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.人类卵巢肿瘤中自然杀伤活性存在缺陷:原位存在的形态学明确的效应细胞数量较少。
J Natl Cancer Inst. 1983 Jan;70(1):21-6.
2
Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.干扰素对外周血及肿瘤相关淋巴细胞针对人卵巢癌细胞的细胞毒性的影响。
J Natl Cancer Inst. 1982 Apr;68(4):555-62.
3
Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.腹水型卵巢癌中肿瘤相关淋巴细胞对自然杀伤活性的抑制作用。
J Natl Cancer Inst. 1981 Aug;67(2):319-25.
4
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.卵巢癌患者肿瘤相关T细胞和自然杀伤细胞中信号转导蛋白的表达及功能改变。
Clin Cancer Res. 1996 Jan;2(1):161-73.
5
Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.从腹水型卵巢肿瘤患者分离出的肿瘤相关淋巴细胞和外周血淋巴细胞的淋巴因子激活的杀伤活性。
J Natl Cancer Inst. 1986 Oct;77(4):863-8.
6
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.VLA - 6(CDw49f)是自体或异基因骨髓移植后自然杀伤细胞介导的细胞毒性中的一种重要黏附分子。
Exp Hematol. 1995 Dec;23(14):1530-4.
7
Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.人类自然杀伤细胞的异质性:对裂解单纯疱疹病毒1型感染的成纤维细胞和K562红白血病靶细胞的效应细胞的比较
J Immunol. 1983 Apr;130(4):1663-7.
8
Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.结肠癌患者自然杀伤淋巴细胞异常的异质性。
Surgery. 1984 Jan;95(1):63-70.
9
Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.癌症患者自然细胞毒性缺陷:效应细胞数量正常,但晚期疾病患者的再循环能力下降。
J Immunol. 1982 Nov;129(5):2255-9.
10
Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.单细胞水平的细胞介导细胞毒性机制。VI. 人外周血非裂解效应细胞-靶细胞共轭物细胞毒性潜力的直接评估。
J Immunol. 1984 Feb;132(2):594-8.

引用本文的文献

1
Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas.探索基于自然杀伤细胞的免疫疗法靶向高级别浆液性卵巢癌的潜力。
Vaccines (Basel). 2024 Jun 18;12(6):677. doi: 10.3390/vaccines12060677.
2
Setting traps for NKG2A gives NK cell immunotherapy a fighting chance.针对 NKG2A 设陷阱,让 NK 细胞免疫疗法有一线生机。
J Clin Invest. 2019 Apr 15;129(5):1839-1841. doi: 10.1172/JCI128480.
3
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.基于自然杀伤细胞的免疫疗法在妇科恶性肿瘤中的应用:综述
Front Immunol. 2018 Jan 5;8:1825. doi: 10.3389/fimmu.2017.01825. eCollection 2017.
4
Tumor Immuno-Environment in Cancer Progression and Therapy.肿瘤免疫环境在癌症进展和治疗中的作用。
Adv Exp Med Biol. 2017;1036:1-18. doi: 10.1007/978-3-319-67577-0_1.
5
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.重新审视免疫监视与免疫刺激:对癌症免疫治疗的启示。
J Transl Med. 2005 Feb 8;3(1):8. doi: 10.1186/1479-5876-3-8.
6
Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.一种链球菌制剂(OK432)对人卵巢癌肿瘤相关淋巴细胞自然杀伤活性及新鲜卵巢肿瘤细胞裂解的影响。
Br J Cancer. 1983 Oct;48(4):515-25. doi: 10.1038/bjc.1983.224.
7
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.人类乳腺良恶性疾病中主要组织相容性抗原的表达及白细胞浸润
Br J Cancer. 1984 Feb;49(2):161-72. doi: 10.1038/bjc.1984.28.
8
Natural killer cells in human solid tumors.人类实体瘤中的自然杀伤细胞。
Cancer Metastasis Rev. 1983;2(4):337-50. doi: 10.1007/BF00048566.
9
The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma.结直肠癌中单核细胞浸润的分析
J Cancer Res Clin Oncol. 1985;109(2):142-51. doi: 10.1007/BF00391889.
10
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.纤维蛋白原与培养的内皮细胞之间的相互作用。迁移诱导与特异性结合。
J Clin Invest. 1985 Jan;75(1):11-8. doi: 10.1172/JCI111661.